Vireo Growth (VREOF) Non-Current Assets (2020 - 2026)

Vireo Growth's (VREOF) quarterly Non-Current Assets came in at $670.5 million in Q1 2026, up 1279.27% year-on-year from $48.6 million in Q1 2025, and up 30.93% quarter-over-quarter from $512.1 million in Q4 2025.

Vireo Growth (VREOF) Non-Current Assets (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Non-Current Assets across 7 years of filings, most recently posting $670.5 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $670.5 million, up 1279.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 884.23% YoY), and the FY2025 annual result was $512.1 million, up 956.06% from the prior year.
  • Non-Current Assets came in at $670.5 million for Q1 2026 at Vireo Growth, up from $512.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $670.5 million in Q1 2026 to a low of $34.4 million in Q4 2023.
  • The 5-year median for Non-Current Assets is $49.9 million (2024), against an average of $162.8 million.
  • Across the five-year window, Non-Current Assets tumbled 69.4% in 2023 and soared 1279.27% in 2026, its largest moves.
  • Vireo Growth's Non-Current Assets stood at $112.4 million in 2022, then sank by 69.39% to $34.4 million in 2023, then soared by 40.92% to $48.5 million in 2024, then soared by 956.06% to $512.1 million in 2025, then surged by 30.93% to $670.5 million in 2026.
  • The last three Non-Current Assets figures came in at $670.5 million (Q1 2026), $512.1 million (Q4 2025), and $371.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 26.33 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 8.68 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 3.84 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2.47 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 9.64 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.90 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.22 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.40 Bn
10 Vireo Growth - - 59.30 Mn 670.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 670.50 Mn
Dec 31, 2025 512.10 Mn
Sep 30, 2025 370.95 Mn
Jun 30, 2025 346.55 Mn
Mar 31, 2025 48.61 Mn
Dec 31, 2024 48.49 Mn
Sep 30, 2024 49.90 Mn
Jun 30, 2024 46.05 Mn
Mar 31, 2024 43.71 Mn
Dec 31, 2023 34.41 Mn
Sep 30, 2023 36.56 Mn
Jun 30, 2023 39.58 Mn
Mar 31, 2023 43.08 Mn
Dec 31, 2022 112.43 Mn
Sep 30, 2022 119.46 Mn
Jun 30, 2022 122.43 Mn
Mar 31, 2022 121.98 Mn
Dec 31, 2021 125.33 Mn
Sep 30, 2021 119.41 Mn
Jun 30, 2021 70.71 Mn